Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
118.47
-0.55 (-0.46%)
At close: Aug 15, 2025, 10:14 AM

Gilead Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
28.75B 27.12B 27.28B 27.3B
Cost of Revenue
6.25B 6.5B 5.66B 6.6B
Gross Profit
22.5B 20.62B 21.62B 20.7B
Operating Income
1.66B 7.61B 7.33B 9.92B
Interest Income
281M 376M 106M n/a
Pretax Income
690M 6.86B 5.81B 8.28B
Net Income
480M 5.67B 4.59B 6.22B
Selling & General & Admin
6.09B 6.09B 5.67B 5.25B
Research & Development
5.91B 5.72B 4.98B 4.6B
Other Expenses
8.84B 1.21B 3.64B 939M
Operating Expenses
20.84B 13.01B 14.29B 10.79B
Interest Expense
977M 944M 935M 1B
Selling & Marketing Expenses
3.45B 3.27B 778M 735M
Cost & Expenses
27.09B 19.51B 19.95B 17.39B
Income Tax Expense
211M 1.25B 1.25B 2.08B
Shares Outstanding (Basic)
1.25B 1.25B 1.25B 1.26B
Shares Outstanding (Diluted)
1.25B 1.26B 1.26B 1.26B
EPS (Basic)
0.38 4.54 3.66 4.96
EPS (Diluted)
0.38 4.50 3.64 4.93
EBITDA
4.43B 10.5B 8.85B 11.33B
EBIT
1.67B 7.8B 6.75B 9.28B
Depreciation & Amortization
2.77B 2.69B 2.1B 2.05B